AZN vs BRBS · P/E 28, $288.38B cap vs rev $58.2M
AstraZeneca PLC (AZN) versus Blue Ridge Bankshares Inc (BRBS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Blue Ridge Bankshares Inc (BRBS) is a banks - regional company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported BRBS revenue for 2026-06-30 was $58.2M. Net income was -$459.0K. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. BRBS currently screens at market cap $328.2M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. BRBS currently screens at market cap $328.2M.
Not investment advice. Open the AZN and BRBS stock pages for the full models.
Not investment advice.